Skip to content
Sovereign Tax Atlas
Directory

1v1 Institutional Counterparty Comparison

BHC vs Cytoswap: Regulation, 6D Ratings & Safety Audit

Deterministic head-to-head benchmarking of BHC (BRICKHILL CAPITAL LIMITED) and Cytoswap (Cytoswap) across primary regulatory filings, statutory Tier-1 authorisations, 6-Dimension compliance scores, execution software, and warning exposure.

Coverage: Institutions licensed in offshore financial centres

DETERMINISTIC QUANTITATIVE VERDICTCanonical Pair: bhc-vs-cytoswap

BHC outranks Cytoswap by +3.1 pts in composite 6D scoring (5.1 vs 2.0)

On supervisory breadth, BHC holds 3 active regulated licence(s) (0 Tier-1) out of 3 total filings and 0 warning count(s), whereas Cytoswap holds 0 active regulated licence(s) (0 Tier-1) out of 0 total filings and 0 warning count(s). Allocators should inspect the individual licence numbers and contracting legal entities below before onboarding.

6-Dimension Quantitative Scorecard Comparison

Head-to-head breakdown across all 6 proprietary evaluation dimensions (0.0–10.0 scale).

Evaluation DimensionMethodology WeightBHCCytoswapScore DeltaDimension Leader
Overall Composite 6D Score100% Composite5.12.0+3.1BHC
Regulatory & Licensing Integrity (riskScore)30% Weight3.02.0+1.0BHC
Execution & Software Infrastructure (industryScore)20% Weight3.01.0+2.0BHC
User Reputation & Complaint Telemetry (userScore)20% Weight0.00.00.0Statistical Tie
Institutional Brand Longevity (brandScore)15% Weight5.62.0+3.6BHC
Global Market Influence & Footprint (influenceScore)15% Weight2.02.00.0Statistical Tie

Visual Architecture Benchmark: BHC vs Cytoswap

Vector comparison exhibit generated from live supervisory snapshot metrics.

1v1 Institutional Counterparty Benchmark: BHC vs Cytoswap
Exhibit: Side-by-side regulatory and 6D quantitative comparison between BHC and Cytoswap.

Regulatory Standing, Entity & Platform Comparison

Structural comparison of supervisory authorisations, domicile, execution terminals, and risk telemetry.

Audit AttributeBHCCytoswap
Primary Legal NameBRICKHILL CAPITAL LIMITEDCytoswap
Source Risk ClassificationRisk level not suppliedRisk level not supplied
Active Regulated / Total Filings3 regulated / 3 total (0 Tier-1)0 regulated / 0 total (0 Tier-1)
Recorded Certificate NumbersNone on file
Registered Domicile / Address3rd Floor, Standard Chartered Tower, Cybercity, Ebene, 72201, Republic of MauritiusInternational
Offered Asset Classes & ServicesCFDs, ForexTrading
Execution Software & TerminalsProprietary / Web PlatformProprietary / Web Platform
Supported Client LanguagesOther languages, Chinese (Simplified), EnglishEnglish
Warning / Exposure Count0 recorded warning(s)0 recorded warning(s)

Frequently Asked Questions: BHC vs Cytoswap

Deterministic counterparty comparison answers derived from supervisory records.

Which institution has stronger regulatory oversight: BHC or Cytoswap?

BHC holds more active regulated filings (3 vs 0). Specifically, BHC maintains 3 total recorded filing(s) (Financial Services Commission, Financial Services Commission, Mauritius, CYSEC) with 0 warning flag(s), whereas Cytoswap maintains 0 recorded filing(s) (none on file) with 0 warning flag(s). Always confirm the specific subsidiary onboarding your account on the official regulator register.

How do the 6D quantitative compliance scores compare between BHC and Cytoswap?

In Sovereign Tax Atlas's 6-Dimension scoring matrix (0.0–10.0 scale), BHC records an Overall Score of 5.1 (Risk & Licensing: 3.0, Brand: 5.6, Market Influence: 2.0, User Reputation: 0.0, Execution & Software: 3.0), compared with Cytoswap at 2.0 Overall (Risk & Licensing: 2.0, Brand: 2.0, Market Influence: 2.0, User Reputation: 0.0, Execution & Software: 1.0).

How do BHC and Cytoswap differ in trading platforms and asset classes?

BHC lists CFDs, Forex with execution software [proprietary/web execution], while Cytoswap lists Trading with execution software [proprietary/web execution]. Counterparties should verify FIX/API connectivity, server routing topology, and negative balance protection per entity.

Which counterparty carries lower regulatory warning and complaint exposure: BHC or Cytoswap?

BHC carries a "Risk level not supplied" classification with 0 warning/exposure count(s) and 0 user comment(s), while Cytoswap carries a "Risk level not supplied" classification with 0 warning/exposure count(s) and 0 user comment(s).

Structured against supervisory register snapshots and public regulatory filings. Verify your contracting legal entity and current authorisation status directly on the issuing regulator’s official register before transacting.

BHC vs Cytoswap (2026) — Regulation, 6D Score, Safety & Fee Comparison | Sovereign Tax Atlas